Last reviewed: July 3, 2026 Last updated: July 3, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
She says competition like this, plus the introduction of pill versions, will pressure U.S
We are doing some updates on our site, and we need to be offline for a while
Sherling points out that people who want to keep the weight off are potentially committing to lifelong medication
Some of these medications use different active ingredients, ways of taking the drug, and dosing schedules
But keeping it off after you stop taking the drug can be a big challenge